GLP-1 medications are reshaping the weight loss landscape as more people turn to them to lose weight and improve their overall health. But taking them isn’t as simple as swallowing a pill and waiting for results. Most GLP-1s are self-administered injections, and they require a step-up dosing schedule, where you start at a low dose and gradually increase based on how your body responds.
Get access to prescription weight loss medication with Noom.
FSA/HSA ELIGIBLE
SEMAGLUTIDE
When you begin tirzepatide, the active ingredient in Zepbound® and Mounjaro®, this personalized dosing approach is essential. It helps minimize side effects like nausea or fatigue while supporting steady, sustainable weight loss—ideally around 1 to 2 pounds per week.
Finding the right dose takes time, but it’s critical for long-term success. Clinical trials show that people taking tirzepatide lost an average of 21% of their body weight over 18 months.
Here’s how the dosing process works—and what to expect along the way.
While you might have heard of Mounjaro®or Zepbound®, you may not be familiar with how the tirzepatide in them works. Tirzepatide mimics the actions of two hormones: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). These hormones help regulate blood sugar, slow digestion, and reduce appetite. By targeting two pathways, tirzepatide improves insulin sensitivity and promotes a greater feeling of fullness, leading to significant and sustained weight loss for many people.
Though both medications contain the same active ingredient, they differ in their FDA-approved uses and the contexts in which they’re prescribed. Let’s break it down:
Zepbound® is FDA-approved for weight management in adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related health issue, like high blood pressure or high cholesterol. It can also be prescribed to treat obstructive sleep apnea (OSA).
Mounjaro® is FDA-approved for adults with type 2 diabetes to help manage blood sugar levels. Like Ozempic®, Mounjaro® is often prescribed off-label for weight loss. To qualify for an off-label prescription, you typically need to meet the same BMI markers as for Zepbound®. Mounjaro® is only available as a prefilled injection pen.
As mentioned, finding the right tirzepatide dosage involves starting low and gradually increasing over several months. While there is a roadmap that many people follow, your path might be different. Your healthcare provider will adjust your dose based on your response, comfort, and progress toward weight loss.
Whether you’re using Zepbound® or Mounjaro®, you’ll start on the lowest dose. Both medications are the same and have the same doses, unless you are using the vial and syringe version of Zepbound®, which only goes up to the 10 mg dose*. Here’s a look at the typical pathway:
*If you need to go higher than the 10 mg dose with the vial and syringe, you’ll have to switch to the injector pens.
The cost of the different tirzepatide medications can vary and will increase with the dose if you’re using the vial and syringe option. Let’s go through what you can expect to pay with both.
The dose won’t necessarily be different for weight loss or type 2 diabetes management. It will depend on how your body reacts to the medication in terms of weight loss or blood sugar management, balanced against side effects.
In general, people lost more weight at the higher doses of tirzepatide. People also tended to experience greater diabetes management results at higher doses. According to one study, HbA1c reductions were greater with the 10 mg and 15 mg doses of tirzepatide versus the lower doses.
You don’t have to get the highest dose of tirzepatide to see significant results. Here’s a look at what the clinical studies show about weight loss at different doses.
In the 72-week trial, people were able to lose an average of the following percentage of weight:
For someone starting at 200 pounds, this translates to approximately:
While higher doses typically lead to greater weight loss, they also increase the likelihood of side effects, so your provider will carefully balance effectiveness with comfort.
Both Mounjaro® and Zepbound® are taken as weekly injections under the skin (subcutaneous) that you give yourself. The difference will be if you use the vial and syringe form with Zepbound®. Here’s what you need to know about each method:
Tirzepatide should always be injected just under the skin, never directly into muscle or veins. Common injection sites include:
Rotating injection sites each week helps reduce irritation and improve absorption. Avoid injecting into areas that are bruised, tender, hard, scarred, or have skin conditions.
While semaglutide has a pill called Rybelsus, tirzepatide is only available as an injection. Eli Lilly is currently testing a GLP-1 pill, called orforglipron. Here’s some early info from testing:
The safety profile of orforglipron looks promising, with side effects that were mostly mild to moderate and typical for the GLP-1 class (things like nausea, diarrhea, or constipation). More trial results are expected, including studies on using orforglipron for weight loss, sleep apnea, and high blood pressure. If approved, this GLP-1 pill could offer an alternative to injectable tirzepatide.
Your healthcare provider will personalize your tirzepatide dose to match your individual health goals, comfort, and response. Zepbound® and Mounjaro® follow similar guidelines for dose adjustments and personalization.
Several factors can affect how your provider adjusts your dosage:
Your healthcare provider will adjust your dose depending on how your body responds. Here are a few signs that could mean it’s time to tweak your dose:
